Company
Sydney, NSW
Every investor coverage indicates participated in a round Noxopharm raised.
Companies Noxopharm acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Noxopharm. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Roundup of manufacturing briefs: Macquarie University opens a silicon research lab with Atto Devices, Spectur's managing director resigns, Provaris and Noxopharm secure new funding, and Livium sells its lithium project stake.
Roundup of Australian manufacturing news: federal defence funding for a watercraft builder, a completed Tasmanian bus contract, diagnostics certification, cannabis sales growth, a biotech raise, an acquisition and positive Covid drug trial data.
Manufacturing briefs roundup: Magnis and Charge CCCV report encouraging battery cell test results, Nova Eye starts United States testing of its glaucoma catheter, and Noxopharm collects a government research rebate.
News briefs covering four manufacturers: Magnis banks $34m for a US battery factory, Bionomics locks in $16m, Noxopharm touts a prostate cancer drug pairing, and SciDev notches its maiden profit.
Also @AuManufacturing
Roundup: Australian Made Campaign names Allyn Beard chairman, Noxopharm raises $23 million for cancer drug trials, and tna Solutions supports a wheelchair factory in Bangladesh through its founders' charity.
Roundup of manufacturing briefs: a $100 million Adelaide digital health fund is set up with SAHMRI and Artesian backing; Noxopharm spins out Pharmorage; AMGC and Australian Made partner; Archer and Stealth announce collaborations.